Triglyceride‐ and Body Weight‐Based Nomogram for Early Postoperative Mycophenolate Mofetil Dose Selection Following Kidney Transplantation
Clinical Transplantation · 2026
DOI: 10.1111/ctr.70696 ↗At a glance
Journal article in Clinical Transplantation, 2026. Written by Tenshi Makiyama and 3 co-authors. Institution: Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan. Major MEDLINE topics: Mycophenolic Acid, Kidney Transplantation, Nomograms, Triglycerides. 19 references. Funded by: JSPS KAKENHI.
Abstract (original language)
Background
Early mycophenolic acid (MPA) exposure varies widely after kidney transplantation, and fixed initial mycophenolate mofetil (MMF) dosing may cause overexposure before therapeutic drug monitoring (TDM) becomes available. We explored routinely available pretransplant clinical variables and developed a simple pre‐TDM nomogram using triglycerides (TG) and body weight to support early postoperative MMF dose selection in tacrolimus‐treated recipients.
Methods
In this single‐center retrospective derivation study, 117 consecutive adult kidney transplant recipients were screened, and 116 with complete concentration profiles were analyzed. All received tacrolimus‐based immunosuppression; none received cyclosporine. A model incorporating concurrent MMF dose, pretransplant body weight, and pretransplant TG was standardized to 1500 mg/day. A three‐level rule (1000/1500/2000 mg/day) was evaluated using dose‐proportional simulation. False discovery rate (FDR) correction, internal validation, and alternative dose–exposure assumptions were examined.
Results
Observed MPA AUC categories were < 30, 30–60, and > 60 mg·h/L in 12.1%, 46.6%, and 41.4% of recipients, respectively. TG survived dose‐adjusted multiplicity correction ( q = 0.047), but not unadjusted correction. Under simulated nomogram‐guided dosing, the corresponding proportions were 14.7%, 54.3%, and 31.0%, a reduction in overexposure of 10.4 percentage points (bootstrap 95% confidence interval, −18.1–−3.4). Across alternative assumptions, the reduction ranged from −1.7–−10.4 percentage points and target‐attainment improvement was not robust; internal validation was directionally consistent but imprecise.
Conclusions
The nomogram showed a directionally consistent but assumption‐dependent reduction in simulated early MPA overexposure. It is a hypothesis‐generating pre‐TDM tool and should not replace AUC‐guided TDM or clinical judgment. Prospective external validation is required.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Frontier Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Funding
- JSPS KAKENHI
Cite
APA
Makiyama, T., Kinoshita, K., Morimoto, A., & Maruyama, M. (2026). Triglyceride‐ and Body Weight‐Based Nomogram for Early Postoperative Mycophenolate Mofetil Dose Selection Following Kidney Transplantation. Clinical Transplantation. https://doi.org/10.1111/ctr.70696
Vancouver
Makiyama T, Kinoshita K, Morimoto A, Maruyama M. Triglyceride‐ and Body Weight‐Based Nomogram for Early Postoperative Mycophenolate Mofetil Dose Selection Following Kidney Transplantation. Clinical Transplantation. 2026. doi:10.1111/ctr.70696
BibTeX
@article{Makiyama2026,
author = {Makiyama, Tenshi and Kinoshita, Kazuya and Morimoto, Akane and Maruyama, Michihiro},
title = {Triglyceride‐ and Body Weight‐Based Nomogram for Early Postoperative Mycophenolate Mofetil Dose Selection Following Kidney Transplantation},
journal = {Clinical Transplantation},
year = {2026},
doi = {10.1111/ctr.70696}
}
EUVIMED